{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:19:30Z","timestamp":1791328770628,"version":"4.3.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003011","name":"Immune Deficiency Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI101093"],"award-info":[{"award-number":["AI101093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI086037"],"award-info":[{"award-number":["AI086037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI061093"],"award-info":[{"award-number":["AI061093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI48693"],"award-info":[{"award-number":["AI48693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MO 2160\/2-1"],"award-info":[{"award-number":["MO 2160\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI095848"],"award-info":[{"award-number":["AI095848"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI082713"],"award-info":[{"award-number":["AI082713"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI071087"],"award-info":[{"award-number":["AI071087"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI061093"],"award-info":[{"award-number":["AI061093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jaci.2015.08.040","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T16:54:02Z","timestamp":1445705642000},"page":"889-898.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["CD19 controls Toll-like receptor 9 responses in human B\u00a0cells"],"prefix":"10.1016","volume":"137","author":[{"given":"Henner","family":"Morbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Schickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Reisli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Meffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2015.08.040_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1373518","article-title":"CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes","volume":"256","author":"Carter","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jaci.2015.08.040_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(00)80418-5","article-title":"The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity","volume":"6","author":"Tedder","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.08.040_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ni892","article-title":"Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function","volume":"4","author":"Anzelon","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib4","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.4049\/jimmunol.162.8.4438","article-title":"Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase","volume":"162","author":"Buhl","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1074-7613(00)00007-8","article-title":"CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification","volume":"13","author":"Fujimoto","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.08.040_bib6","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.4049\/jimmunol.168.11.5465","article-title":"Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction","volume":"168","author":"Fujimoto","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1074-7613(95)90157-4","article-title":"Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule","volume":"3","author":"Engel","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.08.040_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/376352a0","article-title":"Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice","volume":"376","author":"Rickert","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2015.08.040_bib9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"van Zelm","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2015.08.040_bib10","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/hmg\/ddr068","article-title":"Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation","volume":"20","author":"van Zelm","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2015.08.040_bib11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaci.2010.10.019","article-title":"Defects in the CD19 complex predispose to glomerulonephritis, as well as IgG1 subclass deficiency","volume":"127","author":"Vince","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib12","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.176.3.1978","article-title":"TLR9 activation is defective in common variable immune deficiency","volume":"176","author":"Cunningham-Rundles","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib13","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1172\/JCI69854","article-title":"CVID-associated TACI mutations affect autoreactive B cell selection and activation","volume":"123","author":"Romberg","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.08.040_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2009.05.019","article-title":"Toll-like receptor 7 and 9 defects in common variable immunodeficiency","volume":"124","author":"Yu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1069::AID-IMMU1069>3.0.CO;2-M","article-title":"Impaired up-regulation of CD86 in B cells of \u201ctype A\u201d common variable immunodeficiency patients","volume":"30","author":"Denz","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib16","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2012-07-440776","article-title":"IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients","volume":"120","author":"Weller","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.08.040_bib17","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through Toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib19","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2006-03-008441","article-title":"CpG DNA activation and plasma-cell differentiation of CD27-naive human B cells","volume":"109","author":"Huggins","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.08.040_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.immuni.2008.09.015","article-title":"IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans","volume":"29","author":"Isnardi","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.08.040_bib21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.1202115","article-title":"Luning Prak ET, Shlomchik MJ. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation","volume":"190","author":"Nickerson","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2015.08.040_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/gene.2010.22","article-title":"B-cell maturation and antibody responses in individuals carrying a mutated CD19 allele","volume":"11","author":"Artac","year":"2010","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2015.08.040_bib24","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/hmg\/3.10.1751","article-title":"Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase","volume":"3","author":"Conley","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2015.08.040_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.0105-2896.2005.00233.x","article-title":"Genetic analysis of patients with defects in early B-cell development","volume":"203","author":"Conley","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2015.08.040_bib26","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1172\/JCI61788","article-title":"Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy","volume":"122","author":"Sauer","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2015.08.040_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/emmm.201201595","article-title":"Carabin deficiency in B cells increases BCR-TLR9 costimulation-induced autoimmunity","volume":"4","author":"Schickel","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jaci.2015.08.040_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0092-8674(00)80828-4","article-title":"HIV-1 genome nuclear import is mediated by a central DNA flap","volume":"101","author":"Zennou","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2015.08.040_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/smim.1998.9999","article-title":"CD19 regulates B lymphocyte responses to transmembrane signals","volume":"10","author":"Fujimoto","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri1056","article-title":"PI3K in lymphocyte development, differentiation and activation","volume":"3","author":"Okkenhaug","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood-2007-08-109769","article-title":"Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase","volume":"111","author":"Aiba","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.08.040_bib32","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.2305","article-title":"DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation","volume":"13","author":"Jabara","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib33","doi-asserted-by":"crossref","first-page":"36953","DOI":"10.1074\/jbc.M707682200","article-title":"Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase","volume":"282","author":"Doyle","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2015.08.040_bib34","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1182\/blood-2012-12-475111","article-title":"A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia","volume":"122","author":"Yang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.08.040_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","article-title":"Toll-like receptors in systemic autoimmune disease","volume":"6","author":"Marshak-Rothstein","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib37","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1084\/jem.186.11.1897","article-title":"Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization","volume":"186","author":"Buhl","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.08.040_bib38","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.4049\/jimmunol.167.5.2469","article-title":"A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice","volume":"167","author":"Hasegawa","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni890","article-title":"PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction","volume":"4","author":"Suzuki","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/ni.2685","article-title":"Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cells","volume":"14","author":"Castello","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1073\/pnas.1111957108","article-title":"B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K","volume":"109","author":"Ni","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.08.040_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1073\/pnas.1118579109","article-title":"Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine\/threonine kinases PI3K\/Akt","volume":"109","author":"Troutman","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2015.08.040_bib43","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1084\/jem.20101111","article-title":"CD14 is a coreceptor of Toll-like receptors 7 and 9","volume":"207","author":"Baumann","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.08.040_bib44","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/ni.1908","article-title":"Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b","volume":"11","author":"Han","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib45","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2002-11-3573","article-title":"CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes","volume":"102","author":"Yazawa","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2015.08.040_bib46","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1084\/jem.20082392","article-title":"Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity","volume":"206","author":"Kubo","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2015.08.040_bib47","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2014.07.042","article-title":"Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells","volume":"134","author":"Janssen","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2015.08.040_bib48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He","year":"2010","journal-title":"Nat Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915012658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674915012658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:58:41Z","timestamp":1758790721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674915012658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0091674915012658"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2015.08.040","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD19 controls Toll-like receptor 9 responses in human B\u00a0cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2015.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}